1.
Medical Research Council Media Release
File Format: Microsoft Word For further information about Cancer Research UK's work or to find out how to ... http://info.cancerresearchuk.org/healthyliving/obesityandweight/bodymassindex/
2.
Second Chinese Cardiac Study (CCS-2) — CTSU
Hence, patients will be randomly allocated in CCS-2 to receive metoprolol or matching placebo for up to 4 weeks (in addition to any fibrinolytic or ...
3.
Glasgow Royal Infirmary — CTSU
Glasgow Royal Infirmary. HPS Centre ID 55. Total patients recruited: 235 ... Maidstone Hospital · Kettering General Hospital · Queen Elizabeth Hospital, Birmingham ... Clinical Trial Service Unit, Richard Doll Building, Old Road Campus,
4.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) — CTSU
The EBCTCG process was initiated in 1983; the first cycle collected data for hormonal and cytotoxic therapy in 1985 [6a, 6b]; the collaboration was extended ...
5.
UK Economic Evaluation Slideshow Presentation — CTSU
Jun 6, 2008 ... The slideshow presentation of the HPS UK economic evaluation results is available in two formats: View now in your browser ...
6.
India Tuberculosis and Smoking — CTSU
Feb 6, 2006 ... Half the male tuberculosis deaths in India are caused by smoking, and three quarters of the smokers who become ill with tuberculosis (TB) ...
7.
Regimen C Induction 1
File Format: PDF/Adobe Acrobat Regimen C Induction 1. Flowchart 15a. Patients from regimen A start at day 15 and receive days 15-35 ... Regimen C - Escalating Capizzi no 1. Flowchart 17 ...
8.
Manchester Royal Infirmary — CTSU
Manchester Royal Infirmary. HPS Centre ID 26. Total patients recruited: 603 ... Telephone: +44 (0)1865 743743; Fax: +44 (0)1865 743985. ...
9.
Independent report on cancer analyses in the SEAS, SHARP and ...
File Format: PDF/Adobe Acrobat - View as HTML independent metaanalysis of these results was previously provided to regulatory authorities in Europe by the CTSU. 2. Results from 2000 patients in SEAS ...
10.
GLOSSARY OF TERMS
The treatment a participant receives in ASCEND (either aspirin or placebo and either omega-3 fatty acid or placebo) is randomly allocated by computer. ...
